SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Genpharmasec Ltd

BSE: 531592 NSE: ISIN: INE861N01036
  |   Sector:  Miscellaneous   |   Industry:  Trading

Snapshot

Q.1 Which industry/sub-sector does Genpharmasec Ltd belong to?
Genpharmasec Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.2 Is Genpharmasec Ltd a good quality company?
Genpharmasec Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Genpharmasec Ltd undervalued or overvalued?
Genpharmasec Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Genpharmasec Ltd a good buy now?
Genpharmasec Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Genpharmasec Ltd?
Genpharmasec Ltd revenue growth is 8.4% for FY-2025 , which is below its 5 year CAGR of 14.8% , indicating slower growth.
Q.2 Gross Profit margin of Genpharmasec Ltd?
Genpharmasec Ltd Gross profit margin which is the profit after deduction of direct costs, is 10.9% for FY-2025 , which is above its 5 year median of 1.6% , indicating increasing margins.
Q.3 Operating Profit Margin of Genpharmasec Ltd?
Genpharmasec Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 1.34% for FY-2025 , which is above its 5 year median of 1.01% indicating increasing margins.
Q.4 Net Profit Margin of Genpharmasec Ltd?
Genpharmasec Ltd Net Profit Margin is 7.49% for FY-2025 , is above with its 5 year median of 4.41%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 10.9 1.6
Operating Profit Margin 1.34 1.01
Net Profit Margin 7.49 4.41
Q.5 Return on Asset of Genpharmasec Ltd?
Genpharmasec Ltd Return on Asset is 3.31%, which is in line with its 5 year historical median of 3.31%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Genpharmasec Ltd?
Genpharmasec Ltd Return on equity is 3.77% for FY-2025 , which is in line with its historical median of 3.77%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Genpharmasec Ltd?
Genpharmasec Ltd Return on capital employed is 5.44% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Genpharmasec Ltd?
Genpharmasec Ltd Cash conversion cycle is 156 days, below its historical median of 156 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.44 0.81
ROE 3.77 3.77
ROCE 5.44 2
Cash Conversion Cycle 156 days 156 days
Q.9 Debt to Equity ratio of Genpharmasec Ltd?
Genpharmasec Ltd Debt-to-Equity ratio is 0.05 , which is above with the industry average of 0.03 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Genpharmasec Ltd?
Genpharmasec Ltd Debt to cash flow from operations is 0.91 , which is at a healthy level, indicating the business is able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Genpharmasec Ltd?
Promoters hold 29.98% of the Genpharmasec Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Genpharmasec Ltd vs industry peers?
Genpharmasec Ltd revenue CAGR is 14.84% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 33 13.3
Gross Profit 3.6 0.4
Operating Profit 0.4 0
Net Profit 2.5 0.3
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.44 0.5
ROE 3.77 2.03
ROCE 5.44 3.6
Cash Conversion Cycle (days) 156.5 41

Valuation & price assessment

Q.1 Stock return of Genpharmasec Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 20.9% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 20.9% -25.1% -18.4% -45.2%
Q.3 Valuation ratios of Genpharmasec Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 21.38 122.58 21.75
Price to Book 0.89 12.52 1.55
Price to Sales 0.67 11.33 1.87
EV to EBITDA 14.66 114.06 13.67

Check more companies

1. Aditya Infotech
2. Aegis Logistics
3. Redington
4. RRP Semiconductor
5. Honasa Consumer
6. Lloyds Enterprises
7. Cello World
8. MMTC
9. Jeena Sikho Life
10. SG Mart
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×